Skip to content

StratCare Trial

Pragmatic randomised controlled trial of a stratified care model for depression and anxiety

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN11106183
Enrollment
760
Registered
2018-07-27
Start date
2018-08-13
Completion date
Unknown
Last updated
2023-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Common mental health problems (depression, anxiety) Mental and Behavioural Disorders

Interventions

Psychological therapists who carry out mental health assessments in routine primary care services will be randomly assigned to an experimental group (StratCare) or a usual care control group. Therap

Sponsors

University of Sheffield
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Consenting psychological wellbeing practitioners and psychotherapists that carry out routine assessments in an IAPT service (Improving Access to Psychological Therapies programme in England) 2. Therapists who are employed by a participating IAPT service on a permanent contract, or temporary staff who have a contract that is at least as long as the expected timescale for the project (1 year) 3. All consenting patients who are assessed by participating therapists, who are deemed eligible for treatment in IAPT, and who attend at least one post-assessment therapy session

Exclusion criteria

Exclusion criteria: 1. Therapists whose contract is shorter than the expected timescale for the study (1 year) 2. Therapists currently in training, since they are not yet fully qualified to carry out routine assessments 3. Patients who are assessed as ineligible for treatment in IAPT (eg, those who are signposted to other services), or eligible patients who never attend any therapy sessions after an initial assessment contact

Design outcomes

Primary

MeasureTime frame
Depression measured using PHQ-9 pre (initial assessment) and post-treatment (final therapy session)

Secondary

MeasureTime frame
1. Anxiety measured using GAD-7 pre (initial assessment) and post-treatment (final therapy session) 2. Treatment dropout rates, as recorded in routine clinical records 3. Therapists' adherence to the StratCare treatment recommendations, as measured by statistical reliability indices (hit rates, and treatment-matching precision scores) 4. Cost-effectiveness of the StratCare model by comparison to usual care, determined using a cost-effectiveness acceptability curve (CEAC)

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 13, 2026